Update on the acquisition of InvestAcc
30/09/2024 16:58
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240930:nRSd3174Ga&default-theme=true
RNS Number : 3174G Marwyn Acquisition Company II Ltd 30 September 2024
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE,
PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN
OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA,
JAPAN OR ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO.
THIS IS AN ANNOUNCEMENT AND NOT A PROSPECTUS OR A PROSPECTUS EQUIVALENT
DOCUMENT AND INVESTORS AND PROSPECTIVE INVESTORS SHOULD NOT MAKE ANY
INVESTMENT DECISION ON THE BASIS OF ITS CONTENTS. A PROSPECTUS IN RELATION TO
THE ACQUISITION WAS PUBLISHED ON 1 JULY 2024 ("ORIGINAL PROSPECTUS") WHICH WAS
SUPPLEMENTED BY A SUPPLEMENTARY PROSPECTUS DATED 3 SEPTEMBER 2024.
30 September 2024
LEI: 2549008KZ7HM27V4O637
Marwyn Acquisition Company II Limited
(the "Company")
Update on the acquisition of InvestAcc
Further to the Company's announcement on 28 June 2024 that it has entered into
a binding agreement to acquire 100 per cent. of the issued share capital of
InvestAcc Group Limited ("InvestAcc") a leading pensions services provider,
the Company is pleased to announce that it has received the necessary
regulatory approvals from the Financial Conduct Authority ("FCA") in respect
of the change in control of the entities in the InvestAcc Group that are FCA
authorised and will therefore proceed to Completion.
Accordingly, Completion of the Acquisition is expected to occur on 9 October
2024 subject to the FCA agreeing to the Re-Admission of the Enlarged Ordinary
Share Capital of the Company to the equity shares (transition) category of the
Official List and the London Stock Exchange having acknowledged that the
Enlarged Ordinary Share Capital will be admitted to trading on its main market
for listed securities, in each case with effect from Completion.
Expected Timetable
All times shown are London times unless otherwise stated. All dates and times
are based on the current expectations of the Company and are subject to
change. If any of the dates and/or times in this expected timetable change,
the revised dates and/or times will be notified by announcement through a
Regulatory Information Service.
Event Time and / or date
Expected date of Completion Before 8 a.m. on 9 October 2024
Cancellation of the listing of the Ordinary Shares on the London Stock 8 a.m. on 9 October 2024
Exchange
Admission of the Consideration Shares 8 a.m. on 9 October 2024
Re-Admission of the Ordinary Shares 8 a.m. on 9 October 2024
Despatch of definitive certificates in respect of the By no later than 14 days after
Consideration Shares Re-Admission
Defined terms used in this announcement shall have the meaning given in the
Original Prospectus, unless otherwise defined.
Enquiries:
Company Secretary
Antoinette Vanderpuije - 020 7004 2700
Zeus Capital Limited - Corporate Broker - +44 (0) 207 220 1666
Harry Ansell
Katy Mitchell
Panmure Liberum Capital Limited (Financial Adviser) - 44 (0) 203 100 2000
Chris Clarke / Ed Thomas / Anake Singh
IMPORTANT NOTICES
Neither this announcement nor any copy of it may be taken or transmitted
directly or indirectly into or from any jurisdiction where to do so would
constitute a violation of the relevant laws or regulations of such
jurisdiction. Any failure to comply with this restriction may constitute a
violation of such laws or regulations. Persons into whose possession this
announcement or other information referred to herein comes should inform
themselves about, and observe, any restrictions in such laws or regulations.
This announcement has been prepared for the purpose of complying with the
applicable law and regulation of the United Kingdom and information disclosed
may not be the same as that which would have been disclosed if this
announcement had been prepared in accordance with the laws and regulations of
jurisdictions outside the United Kingdom.
This announcement does not constitute or form part of any offer, invitation to
sell, otherwise dispose of or issue, or any solicitation of any offer to
purchase or subscribe for, any shares or other securities nor shall it or any
part of it, nor the fact of its distribution form the basis of, or be relied
on in connection with, any contract commitment or investment decision.
This announcement does not constitute an offer of securities for sale in the
United States or an offer to acquire or exchange securities in the United
States. No offer to acquire securities or to exchange securities for other
securities has been made, or will be made, directly or indirectly, in or into,
or by use of the mails, any means or instrumentality of interstate or foreign
commerce or any facilities of a national securities exchange of, the United
States or any other country in which such offer may not be made other than:
(i) in accordance with applicable United States securities laws or the
securities laws of such other country, as the case may be; or (ii) pursuant to
an available exemption from such requirements. The securities referred to
herein have not been and will not be registered under the U.S. Securities Act
of 1933, as amended, or under the securities laws of any state or other
jurisdiction of the United States.
Panmure Liberum Capital ("Panmure Liberum") is authorised and regulated in the
United Kingdom by the FCA and is acting as financial adviser for the Company
and no one else in connection with the matters described in this announcement.
Panmure Liberum will not regard any other person as its client in relation to
the matters described in this announcement and will not be responsible to
anyone other than the Company for providing the protections afforded to its
clients or for providing advice to any other person in relation to the matters
referred to in this announcement.
This announcement is not a prospectus but an advertisement. Neither this
announcement nor anything contained in it shall form the basis of, or be
relied upon in conjunction with, any offer or commitment whatsoever in any
jurisdiction. Investors should not acquire any Ordinary Shares referred to in
this announcement except on the basis of the information contained in the
Original Prospectus and the Supplementary Prospectus published by the Company.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END ACQWPUQABUPCGAU